134.3 million mostly from trade payables and short-term loans of Baht 224.6 million to support higher production. Meanwhile, long- term liabilities decreased by Baht 97 million for the repayment. As a
THB 61 million. 4. Other payables and accrued expenses decreased by THB 96 million. 5. Long-term loan from other parties decreased by THB 341 million. Total equity As of 30 June 2018, the Company has
financial institutions decreased by Baht 4.05 million Trade and other payables increased by Baht 18.15 million Provisions for employee benefit increase by Baht 1.6 million Other current liabilities increase
subsidiary. As at 30 September 2018, the Company had consolidated liabilities increased from last year by Baht 244.73 million mainly from trade payables and short-term loans to support higher in working
long-term loan repayment to financial institutions by Baht 49.72 million, and a Baht 20.51 million decline in trade and other payables, which was mainly บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2
. 3. Short-term loan from related parties decreased by THB 173 million. 4. Accrued interest expenses decreased by THB 58 million. 5. Other payables and accrued expenses decreased by THB 169 million. 6
92.99 million as of 30 September 2018, an increase from Baht 70.83 million as of 31 December 2017, mostly due to account payables. Non-Current Liabilities were Baht 8.86 million as of 30 September 2018
Short term loan from Financial Inst. 90.1 3.6% 76.3 3.1% 13.8 18.1% Trade and other payables 99 3.9% 123.6 5.0% -24.6 -19.9% Management Discussion and Analysis, Q3/2018 Page3/4 As of 30 Sep 2018 As of
) -29% Total Liabilities 3,407 2,544 862 34% Bank overdrafts and short-term loans from banks 905 704 201 29% Trade and other payables 86 83 3 4% Other current liabilities 20 18 2 12% Total shareholders
of accounts payable, other payables, advances received from employers, short-term bank loan and debenture. Total shareholders’ equity amounted to Baht 25,508.09 million, an increase of Baht 1,635.01